Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27(Kip1)

被引:224
|
作者
CasacciaBonnefil, P
Tikoo, R
Kiyokawa, H
Friedrich, V
Chao, MV
Koff, A
机构
[1] MEM SLOAN KETTERING CANC CTR,PROGRAM MOL BIOL,NEW YORK,NY 10021
[2] CORNELL UNIV,COLL MED,DEPT ANAT & CELL BIOL,NEW YORK,NY 10021
[3] CORNELL UNIV,COLL MED,DEPT NEUROL & NEUROSCI,NEW YORK,NY 10021
[4] CUNY MT SINAI SCH MED,BROOKDALE CTR MOL BIOL,NEW YORK,NY 10029
关键词
oligodendrocyte progenitor cells; cell proliferation; differentiation; CKI p27(Kip1);
D O I
10.1101/gad.11.18.2335
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During development of the central nervous system, oligodendrocyte progenitor cells (O-2A) undergo an orderly pattern of cell proliferation and differentiation, culminating in the ability of oligodendrocytes to myelinate axons. Here we report that p27(Kip1), a cyclin-dependent kinase inhibitor, is an important component of the decision of O-2A cells to withdraw from the cell cycle. In vitro, accumulation of p27 correlates with differentiation of oligodendrocytes. Furthermore, only a fraction of O-2A cells derived from p27-knockout mice differentiate successfully compared to controls. Inability to differentiate correlates with continued proliferation, suggesting that p27 is an important component of the machinery required for the G(1)/G(0) transition in O-2A cells. In vivo, expansion of O-2A precursors before withdrawal, in part, leads to a greater number of oligodendrocytes. Together these data indicate a role for p27 during the decision to withdraw from the cell cycle in the oligodendrocyte lineage.
引用
收藏
页码:2335 / 2346
页数:12
相关论文
共 50 条
  • [21] Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip).
    Kwon, TK
    Nagel, J
    Buchholz, M
    Nordin, A
    [J]. FASEB JOURNAL, 1996, 10 (06): : 2608 - 2608
  • [22] Reduced expression of cyclin-dependent kinase inhibitor p27(Kip1) is associated with advanced stage and invasiveness of gastric carcinomas
    Yasui, W
    Kudo, Y
    Semba, S
    Yokozaki, H
    Tahara, E
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (07): : 625 - 629
  • [23] CONDITIONAL BINDING TO AND CELL-CYCLE-REGULATED INHIBITION OF CYCLIN-DEPENDENT KINASE COMPLEXES BY P27(KIP1)
    EBLEN, ST
    FAUTSCH, MP
    ANDERS, RA
    LEOF, EB
    [J]. CELL GROWTH & DIFFERENTIATION, 1995, 6 (08): : 915 - 925
  • [24] Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/Jab1 correlates with differentiation of embryonal rhabdomyosarcoma
    Tsuchida, R
    Miyauchi, J
    Shen, LS
    Takagi, M
    Tsunematsu, Y
    Saeki, M
    Honna, T
    Yamada, S
    Teraoka, H
    Kato, JY
    Mizutani, S
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (09): : 1000 - 1006
  • [25] Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27(kip1) during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells
    Depoortere, F
    Dumont, JE
    Roger, PP
    [J]. JOURNAL OF CELL SCIENCE, 1996, 109 : 1759 - 1764
  • [26] Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-Cdk2 and cyclin D2-Cdk4
    Blain, SW
    Montalvo, E
    Massague, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) : 25863 - 25872
  • [27] Glomerular expression of the cyclin-dependent kinase (CDK) inhibitor p27(Kip1) in diabetic db/db mouse: Role of hyperglycemia.
    Wolf, G
    Thaiss, F
    Ziyadeh, FN
    Stahl, RK
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3027 - A3027
  • [28] Effect of dibutyryl cyclic AMP on the cyclin-dependent kinase inhibitor p27(Kip1) in the human hepatoma cells PLC/PRF/5
    Kikukawa, M
    Okamoto, Y
    Fukui, H
    Nakano, H
    [J]. ANTICANCER RESEARCH, 1997, 17 (5A) : 3287 - 3291
  • [29] Changes in cyclin-dependent kinase 2 and p27(kip1) accompany glial cell differentiation of central glia-4 cells
    Tikoo, R
    CasacciaBonnefil, P
    Chao, MV
    Koff, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (01) : 442 - 447
  • [30] Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma
    Bayazít, YA
    Karakök, M
    Uçak, R
    Kanlíkama, M
    [J]. LARYNGOSCOPE, 2001, 111 (06): : 1037 - 1041